biosimilars

COVID-19 tests prop up Roche as US biosimilars bite in Q3

https://pharmaphorum.com/news/us-biosimilars-bite-into-roches-pharma-revenues/

Amgen’s cancer biosimilars stay on US market as court battle with Roche ends

https://pharmaphorum.com/news/amgens-cancer-biosimilars-stay-on-us-market-as-court-battle-with-roche-ends/

Breaking policy and perceptual barriers: Biosimilars

https://deep-dive.pharmaphorum.com/magazine/market-access-2020/breaking-policy-and-perceptual-barriers-biosimilars/

Deep Dive: Market Access – Breaking Barriers

https://pharmaphorum.com/views-analysis-market-access/deep-dive-market-access/

Merck & Co spin off could start a trend in big pharma

https://pharmaphorum.com/news/merck-cos-spin-off-closely-watched-by/

3 key trends shaping the immunology market

https://pharmaphorum.com/views-analysis-market-access/3-key-trends-shaping-the-immunology-market/

5 years of biosimilars in the US: what have we learned?

https://pharmaphorum.com/views-analysis-market-access/5-years-of-biosimilars-in-the-us-what-have-we-learned/

J+D Forecasting launches innovative pharmaceutical sales forecasting software

https://pharmaphorum.com/partner-content/jd-forecasting-launches-innovative-pharmaceutical-sales-forecasting-software/

Pfizer launches biosimilars to Roche’s ‘big three’ cancer drugs in US

https://pharmaphorum.com/news/pfizer-launches-biosimilars-to-roches-big-three-cancer-drugs-in-us/

1 2 3 4 5 >»

Close in 10 seconds

Pharmaphorum.com

Search